{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:31:25Z","timestamp":1792697485416,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.retram.2025.103535","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T09:21:29Z","timestamp":1755508889000},"page":"103535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Expert consensus on the management of cytomegalovirus infection in pediatric allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8698-9547","authenticated-orcid":false,"given":"Simone","family":"Cesaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Spadea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Fagioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rabusin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ferrando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Balduzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcangelo","family":"Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zecca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Faraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.retram.2025.103535_bib0001","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for Cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.retram.2025.103535_bib0002","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1473-3099(11)70024-X","article-title":"Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial","volume":"11","author":"Marty","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.retram.2025.103535_bib0003","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/S2352-3026(15)00289-6","article-title":"Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study","volume":"3","author":"Green","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.retram.2025.103535_bib0004","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2016-10-748426","article-title":"The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality","volume":"129","author":"Hill","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.retram.2025.103535_bib0005","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/cid\/cix804","article-title":"Kinetics of double-stranded DNA viremia after allogeneic hematopoietic cell transplantation","volume":"66","author":"Hill","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.retram.2025.103535_bib0006","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/cid\/ciz490","article-title":"A mortality analysis of letermovir prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantation","volume":"70","author":"Ljungman","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.retram.2025.103535_bib0007","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/cid\/ciab1064","article-title":"Impact of Letermovir primary Cytomegalovirus prophylaxis on 1-year mortality after allogeneic hematopoietic cell transplantation: a retrospective cohort study","volume":"75","author":"Su","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.retram.2025.103535_bib0008","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/cid\/ciab988","article-title":"Maribavir for refractory Cytomegalovirus infections with or without resistance post-transplant: results from a phase 3 randomized clinical trial","volume":"75","author":"Avery","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.retram.2025.103535_bib0009","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41409-024-02209-2","article-title":"Letermovir for Cytomegalovirus infection in pediatric patients undergoing allogenic hematopoietic stem cell transplantation: a real-life study by the Infectious Diseases Working Group of Italian Association of Pediatric Hematology-Oncology (AIEOP)","volume":"59","author":"Galaverna","year":"2024","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.retram.2025.103535_bib0010","first-page":"62","article-title":"Letermovir as Cytomegalovirus prophylaxis in a pediatric cohort: a retrospective analysis","volume":"29","author":"Kuhn","year":"2023","journal-title":"Transpl Cell Ther"},{"key":"10.1016\/j.retram.2025.103535_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30608","article-title":"Letermovir for Cytomegalovirus prophylaxis in pediatric hematopoietic stem cell transplantation","volume":"70","author":"Chen","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.retram.2025.103535_bib0012","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1097\/MPH.0000000000002841","article-title":"Use of Maribavir for multidrug resistant cytomegaloviremia in a pediatric oncology patient","volume":"46","author":"Fisher","year":"2024","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.retram.2025.103535_bib0013","doi-asserted-by":"crossref","DOI":"10.1111\/tid.70006","article-title":"Efficacy and safety of Letermovir for Cytomegalovirus prophylaxis in pediatric hematopoietic stem cell transplantation recipients: a systematic review, meta-analysis, and meta-regression","author":"Aldalati","year":"2025","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"10.1016\/j.retram.2025.103535_bib0014","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00525-24","article-title":"Serum ganciclovir drug exposure in children receiving standard ganciclovir dosing","volume":"68","author":"Yang","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.retram.2025.103535_bib0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41409-022-01863-8","article-title":"New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the Infectious Diseases Working Party of EBMT","volume":"58","author":"Cesaro","year":"2023","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.retram.2025.103535_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(25)00069-6","article-title":"Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies","author":"Ljungman","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.retram.2025.103535_bib0017","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/13611260500069947","article-title":"The Delphi technique in health sciences education research","volume":"27","author":"de Villiers","year":"2005","journal-title":"Med Teach"},{"issue":"1","key":"10.1016\/j.retram.2025.103535_bib0018","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/cid\/civ215","article-title":"Reduced mortality of Cytomegalovirus pneumonia after hematopoietic cell transplantation due to antiviral therapy and changes in transplantation practices","volume":"61","author":"Erard","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.retram.2025.103535_bib0019","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/sj.bmt.1703927","article-title":"Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortality","volume":"31","author":"Matthes-Martin","year":"2003","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.retram.2025.103535_bib0020","volume":"30","author":"Klejmont","year":"2024","journal-title":"Transpl Cell Ther"},{"key":"10.1016\/j.retram.2025.103535_bib0021","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00277-021-04707-5","article-title":"Risk factors and outcomes of cytomegalovirus infection in children post cord blood transplantation with focus on impact of graft-versus-host disease and immunosuppressants","volume":"101","author":"Yi","year":"2022","journal-title":"Ann Hematol"},{"key":"10.1016\/j.retram.2025.103535_bib0022","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/bmt.2012.221","article-title":"Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients","volume":"48","author":"Hiwarkar","year":"2013","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.retram.2025.103535_bib0023","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12288-023-01654-1","article-title":"Cytomegalovirus reactivation as a risk factor for all-cause mortality in children undergoing hematopoietic stem cell transplantation: experience over two decades from a tertiary referral center in India","volume":"40","author":"Chakraborty","year":"2024","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.retram.2025.103535_bib0024","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13580","article-title":"Epidemiology and outcome for viremia in children undergoing bone marrow transplant: a retrospective cohort study","volume":"23","author":"Silcock","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.retram.2025.103535_bib0025","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.3390\/jcm11175187","article-title":"The impact of high CMV viral load and refractory CMV infection on pediatric HSCT recipients with underlying non-malignant disorder","volume":"11","author":"Szmit","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.retram.2025.103535_bib0026","doi-asserted-by":"crossref","first-page":"ofab639","DOI":"10.1093\/ofid\/ofab639","article-title":"Risk factors for CMV viremia and treatment-associated adverse events among pediatric hematopoietic stem cell transplant recipients","volume":"9","author":"Heston","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.retram.2025.103535_bib0027","series-title":"2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis","first-page":"e260","article-title":"Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the","volume":"19","author":"Ljungman","year":"2019"},{"key":"10.1016\/j.retram.2025.103535_bib0028","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014172","article-title":"Factors associated with cytomegalovirus infection in children undergoing allogeneic hematopoietic stem-cell transplantation","volume":"98","author":"Jaing","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.retram.2025.103535_bib0029","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.bbmt.2016.04.004","article-title":"Cytomegalovirus infection in pediatric hematopoietic stem cell transplantation: risk factors for primary infection and cases of recurrent and late infection at a single center","volume":"22","author":"Rowe","year":"2016","journal-title":"Biol Blood Marrow Transpl"},{"issue":"9","key":"10.1016\/j.retram.2025.103535_bib0030","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1093\/cid\/ciz1210","article-title":"Cytomegalovirus (CMV) cell-mediated immunity and CMV infection after allogeneic hematopoietic cell transplantation: the REACT study","volume":"71","author":"Chemaly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.retram.2025.103535_bib0031","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3343\/alm.2017.37.3.277","article-title":"Clinical usefulness of monitoring Cytomegalovirus-specific immunity by quantiferon-CMV in pediatric allogeneic hematopoietic stem cell transplantation recipients","volume":"37","author":"Lee","year":"2017","journal-title":"Ann Lab Med"},{"issue":"2","key":"10.1016\/j.retram.2025.103535_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246191","article-title":"Immunologic monitoring of cytomegalovirus (CMV) enzyme-linked immune absorbent spot (ELISPOT) for controlling clinically significant CMV infection in pediatric allogeneic hematopoietic stem cell transplant recipients","volume":"16","author":"Seo","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.retram.2025.103535_bib0033","first-page":"392","article-title":"Immunologic monitoring after allogeneic stem cell transplantation: T-SPOT.CMV and QuantiFERON-CMV, are they the same?","volume":"29","author":"Callens","year":"2023","journal-title":"Transpl Cell Ther"},{"key":"10.1016\/j.retram.2025.103535_bib0034","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.bbmt.2018.05.017","article-title":"Comparative efficacy and safety of different antiviral agents for Cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis","volume":"24","author":"Gagelmann","year":"2018","journal-title":"Biol Blood Marrow Transpl"},{"issue":"16","key":"10.1016\/j.retram.2025.103535_bib0035","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/bloodadvances.2018016493","article-title":"Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation","volume":"2","author":"Chen","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.retram.2025.103535_bib0036","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1182\/blood.2020009362","article-title":"Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis","volume":"137","author":"Goldsmith","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2025.103535_bib0037","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10875-023-01617-1","article-title":"Letermovir for CMV prophylaxis in very high-risk pediatric hematopoietic stem cell transplantation recipients for inborn errors of immunity","volume":"44","author":"C\u00e9sar","year":"2023","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.retram.2025.103535_bib0038","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/bjh.19451","article-title":"Letermovir prophylaxis reduced cytomegalovirus reactivation and resistance post umbilical cord blood transplantation","volume":"204","author":"Yan","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2025.103535_bib0039","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40272-022-00547-6","article-title":"Letermovir for prophylaxis and pre-emptive therapy of Cytomegalovirus infection in paediatric allogeneic haematopoietic cell transplant patients","volume":"25","author":"K\u00f6rholz","year":"2023","journal-title":"Paediatr Drugs"},{"issue":"3","key":"10.1016\/j.retram.2025.103535_bib0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/INF.0000000000004208","article-title":"Pharmacokinetics, safety, and efficacy of Letermovir for Cytomegalovirus prophylaxis in adolescent hematopoietic cell transplantation recipients","volume":"43","author":"Groll","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.retram.2025.103535_bib0041","first-page":"707","article-title":"American Society for Transplantation and Cellular Therapy Series: #3-prevention of Cytomegalovirus infection and disease after hematopoietic cell Transplantation","volume":"27","author":"Hakki","year":"2021","journal-title":"Transpl Cell Ther"},{"key":"10.1016\/j.retram.2025.103535_bib0042","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13666","article-title":"Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: a multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies","volume":"33","author":"Girmenia","year":"2019","journal-title":"Clin Transpl"},{"issue":"2","key":"10.1016\/j.retram.2025.103535_bib0043","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/bmt.2013.164","article-title":"Survey of CMV management in pediatric allogeneic HSCT programs, on behalf of the inborn errors, infectious diseases and pediatric diseases working parties of EBMT","volume":"49","author":"Bontant","year":"2014","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.retram.2025.103535_bib0044","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/idr16010005","article-title":"Management of Cytomegalovirus infections in the era of the novel antiviral players, Letermovir and Maribavir","volume":"16","author":"Piret","year":"2024","journal-title":"Infect Dis Rep"},{"issue":"3","key":"10.1016\/j.retram.2025.103535_bib0045","first-page":"361","article-title":"Effectiveness of prophylactic Human Cytomegalovirus hyperimmunoglobulin in preventing Cytomegalovirus infection following transplantation: a systematic review and meta-analysis","volume":"12","author":"Barten","year":"2022","journal-title":"Life (Basel)"},{"issue":"5","key":"10.1016\/j.retram.2025.103535_bib0046","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1200\/JCO.2008.16.8450","article-title":"Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis","volume":"27","author":"Raanani","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.retram.2025.103535_bib0047","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41409-018-0166-9","article-title":"Cytotect\u00aeCP as salvage therapy in patients with CMV infection following allogeneic hematopoietic cell transplantation: a multicenter retrospective study","volume":"53","author":"Alsuliman","year":"2018","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.retram.2025.103535_bib0048","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2019.048","article-title":"CMV management with specific immunoglobulins: a multicentric retrospective analysis on 92 allotransplanted patients","volume":"11","author":"Malagola","year":"2019","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.retram.2025.103535_bib0049","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.21037\/apm-21-1069","article-title":"A clinical study of lyophilized intravenous human immunoglobulin containing high-titer cytomegalovirus-neutralizing antibody for the treatment of cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation","volume":"10","author":"Zhang","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.retram.2025.103535_bib0050","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1592\/phco.30.6.554","article-title":"Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients","volume":"30","author":"Alexander","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.retram.2025.103535_bib0051","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/AAC.01972-13","article-title":"In vitro combination of anti-cytomegalovirus compounds acting through different targets: role of the slope parameter and insights into mechanisms of action","volume":"58","author":"Cai","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.retram.2025.103535_bib0052","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jcv.2005.09.021","article-title":"Is combination antiviral therapy for CMV superior to monotherapy?","volume":"35","author":"Drew","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.retram.2025.103535_bib0053","first-page":"76","article-title":"Clinical analysis of the efficacies of ganciclovir plus foscarnet and a single antiviral drug for the treatment of cytomegalovirus infection after haploidentical stem cell transplantation]","volume":"62","author":"Ma","year":"2023","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.retram.2025.103535_bib0054","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood-2016-06-688432","article-title":"How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients","volume":"128","author":"El Chaer","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.retram.2025.103535_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1321116","article-title":"Anti-CMV therapy, what next? A systematic review","volume":"14","author":"Gourin","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.retram.2025.103535_bib0056","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/pbc.21043","article-title":"A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients","volume":"49","author":"Shereck","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.retram.2025.103535_bib0057","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1399-3046.2006.00669.x","article-title":"Unexpectedly high inter- and intrapatient variability of ganciclovir levels in children","volume":"11","author":"Vethamuthu","year":"2007","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.retram.2025.103535_bib0058","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/psp4.12363","article-title":"Pediatric dosing of Ganciclovir and Valganciclovir: how model-based simulations can prevent underexposure and potential treatment failure","volume":"8","author":"Jorga","year":"2019","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"10.1016\/j.retram.2025.103535_bib0059","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1186\/s12879-021-06828-8","article-title":"The need for area under the curve measurements in the field of ganciclovir therapeutic drug monitoring in children: a case report","volume":"21","author":"Duval","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.retram.2025.103535_bib0060","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1128\/AAC.40.12.2721","article-title":"Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS","volume":"40","author":"Jr","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.retram.2025.103535_bib0061","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00003495-199448020-00007","article-title":"A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections","volume":"48","author":"Wagstaff","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.retram.2025.103535_bib0062","doi-asserted-by":"crossref","first-page":"e2558","DOI":"10.1002\/rmv.2558","article-title":"Efficacy and safety of adoptive T-cell therapy in treating cytomegalovirus infections post-haematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"34","author":"Taherian","year":"2024","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.retram.2025.103535_bib0063","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1038\/leu.2017.16","article-title":"Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT","volume":"31","author":"Neuenhahn","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2025.103535_bib0064","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.3390\/cancers10040099","article-title":"Treatment options for paediatric anaplastic large cell lymphoma (ALCL): current standard and beyond","volume":"10","author":"Prokoph","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.retram.2025.103535_bib0065","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41375-019-0600-z","article-title":"Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation-a phase I\/II study","volume":"34","author":"Roex","year":"2020","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.retram.2025.103535_bib0066","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1078-0432.CCR-22-2415","article-title":"Posoleucel, an allogeneic, off-the-shelf multivirus-specific T-cell therapy, for the treatment of refractory viral infections in the post-HCT setting","volume":"29","author":"Pfeiffer","year":"2023","journal-title":"Clin Cancer Res"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318625000443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318625000443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:16:30Z","timestamp":1765584990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318625000443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2452318625000443"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2025.103535","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expert consensus on the management of cytomegalovirus infection in pediatric allogeneic hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2025.103535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103535"}}